### Comment:
i have done DD on it in my previous posts, but to sum it up, good cash holdings, pipeline of 5 products, 2 products with catalysts coming up this q3/4 (CarpX ESOcheck). Burn rate has them available to get thru those 2 products, at minimum. no dilution fear.

### REPLY:
You’re not concerned that the FDA made them resubmit their application for CarpX?

### END.